Skip to content

Folic Acid Supplementation in Phenytoin Induced Gingival Overgrowth

Effect of Low Dose Oral Folic Acid Supplementation on Phenytoin Induced Gingival Overgrowth: A Randomized Double Blind Controlled Trial.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00781196
Acronym
PIGO
Enrollment
120
Registered
2008-10-28
Start date
2008-05-31
Completion date
2009-07-31
Last updated
2009-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Overgrowth

Keywords

phenytoin, gum hyperplasia, phenytoin induced gingival overgrowth, plaque index, gingival overgrowth grade

Brief summary

Phenytoin, a common anti-seizure drug, leads to cosmetically unacceptable side effect of gingival overgrowth in a significant number of patients. There is some evidence of therapeutic effect of folic acid in cases of established phenytoin induced gingival overgrowth. In this study, the aim is to study the prospective preventive effect of low dose oral folic acid supplementation on phenytoin induced gingival overgrowth in epileptic children.

Interventions

DRUGfolic acid

capsule 0.5 mg once a day

DRUGplacebo

capsule, once a day

Sponsors

All India Institute of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Age: 6-15 yr * Started on phenytoin within 1 mo of enrollment

Exclusion criteria

* Not willing to participate * On other folic acid antagonists e.g. anti-neoplastic drugs for \>/= 2 wks during last 3 months * Pre-existing gingival over-growth due to other cause

Design outcomes

Primary

MeasureTime frame
Occurrence of any grade of overgrowth in 2 groups after 6 mo of phenytoin therapy6 months

Secondary

MeasureTime frame
Occurrence of grade > 2 hyperplasia at the end of 6 mo6 months
Time to occurrence of grade > 2 overgrowthopen
Correlation between following and occurrence of grade > 2 overgrowth *phenytoin dose (in mg/kg/d) *serum phenytoin levels *plaque index6 months

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026